International Journal of Molecular Sciences · 2021 · 27 citations · 17 references
Life SciencesMolecular BiologyPharmacologyAutophagyInflammationInnate ImmunityAntioxidant DefenseInflammasome ActivationInflammatory MediatorsInflammatory SignalingMitochondrial Redox BiologyReactive Oxygen SpeciesInflammasome ModulationMacrophage Inflammasome ActivationMacrophage Inflammatory ResponsesManganese Superoxide DismutaseMitochondrial Oxidative StressMitochondrial Reactive Oxygen Species ProductionMitochondrial Reactive Oxygen Species SignalingNlr Family Pyrin Domain-containing 3 Inflammasome
Inflammasomes are powerful cytosolic sensors of environmental stressors and are critical for triggering interleukin-1 (IL-1)-mediated inflammatory responses. However, dysregulation of inflammasome activation may lead to pathological conditions, and the identification of negative regulators for therapeutic purposes is increasingly being recognized. Anakinra, the recombinant form of the IL-1 receptor antagonist, proved effective by preventing the binding of IL-1 to its receptor, IL-1R1, thus restoring autophagy and dampening NLR family pyrin domain containing 3 (NLRP3) activity. As the generation of mitochondrial reactive oxidative species (ROS) is a critical upstream event in the activation of NLRP3, we investigated whether anakinra would regulate mitochondrial ROS production. By profiling the activation of transcription factors induced in murine alveolar macrophages, we found a mitochondrial antioxidative pathway induced by anakinra involving the manganese-dependent superoxide dismutase (MnSOD) or SOD2. Molecularly, anakinra promotes the binding of SOD2 with the deubiquitinase Ubiquitin Specific Peptidase 36 (USP36) and Constitutive photomorphogenesis 9 (COP9) signalosome, thus increasing SOD2 protein longevity. Functionally, anakinra and SOD2 protects mice from pulmonary oxidative inflammation and infection. On a preclinical level, anakinra upregulates SOD2 in murine models of chronic granulomatous disease (CGD) and cystic fibrosis (CF). These data suggest that protection from mitochondrial oxidative stress may represent an additional mechanism underlying the clinical benefit of anakinra and identifies SOD2 as a potential therapeutic target.
17
Protection of Cardiac Mitochondria by Overexpression of MnSOD Reduces Diabetic Cardiomyopathy
Xia Shen, Shirong Zheng, Naira Metreveli et al. · Diabetes · 2006 · 376 citations · Full text
Antonella De Luca, Sanne P. Smeekens, Andrea Casagrande et al. · Proceedings of the National Academy of Sciences · 2014 · 314 citations · Full text
Life Sciences, Immunology, Pathology +17